APO Research
Talk to an analyst

APO RESEARCH · REPORT

Herpes Treatment

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Herpes Treatment Market Outlook and Growth Opportunities 2026

22 December 2025195 pages

Choose your research edition.

Industry ResearchHerpes Treatment Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Herpes Treatment Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Herpes Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Herpes Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Herpes Treatment Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Herpes Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Herpes Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Herpes Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Herpes Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Herpes Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Herpes Treatment market include Abbott, Teva Pharmaceutical Industries, Novartis, Merck, Mylan, GlaxoSmithKline, Vical and Gilead, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Herpes Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Herpes Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Herpes Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Herpes Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Herpes Treatment Segment by Company

Abbott

Teva Pharmaceutical Industries

Novartis

Merck

Mylan

GlaxoSmithKline

Vical

Gilead

Herpes Treatment Segment by Type

Famciclovir

Valacyclovir

Acyclovir

Herpes Treatment Segment by Application

Retail Pharmacies

Hospital Pharmacies

Online Pharmacies

Drug Stores

Herpes Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Herpes Treatment status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Herpes Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Herpes Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Herpes Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Herpes Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Herpes Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Herpes Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Herpes Treatment market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Herpes Treatment industry.

Chapter 3: Detailed analysis of Herpes Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Herpes Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Herpes Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Herpes Treatment Industry Trends Table 2. Herpes Treatment Industry Drivers Table 3. Herpes Treatment Industry Opportunities and Challenges Table 4. Herpes Treatment Industry Restraints Table 5. Global Herpes Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Herpes Treatment Revenue Share by Company (2021-2026) Table 7. Global Herpes Treatment Sales Volume by Company (k units) & (2021-2026) Table 8. Global Herpes Treatment Sales Volume Share by Company (2021-2026) Table 9. Global Herpes Treatment Average Price (US$/unit) of Company (2021-2026) Table 10. Global Herpes Treatment Company Ranking, (2024-2026) & (USD Million) Table 11. Global Herpes Treatment Key Company Manufacturing Base & Headquarters Table 12. Global Herpes Treatment Company, Product Type & Application Table 13. Global Herpes Treatment Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Herpes Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Famciclovir Table 18. Significant Companies of Valacyclovir Table 19. Significant Companies of Acyclovir Table 20. Global Herpes Treatment Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Herpes Treatment Sales Volume by Type (2021-2026) & (k units) Table 22. Global Herpes Treatment Sales Volume by Type (2027-2032) & (k units) Table 23. Global Herpes Treatment Sales Volume Share by Type (2021-2026) Table 24. Global Herpes Treatment Sales Volume Share by Type (2027-2032) Table 25. Global Herpes Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Herpes Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Herpes Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Herpes Treatment Sales Value Share by Type (2021-2026) Table 29. Global Herpes Treatment Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Hospital Pharmacies Table 32. Significant Companies of Online Pharmacies Table 33. Significant Companies of Drug Stores Table 34. Global Herpes Treatment Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Herpes Treatment Sales Volume by Application (2021-2026) & (k units) Table 36. Global Herpes Treatment Sales Volume by Application (2027-2032) & (k units) Table 37. Global Herpes Treatment Sales Volume Share by Application (2021-2026) Table 38. Global Herpes Treatment Sales Volume Share by Application (2027-2032) Table 39. Global Herpes Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Herpes Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Herpes Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Herpes Treatment Sales Value Share by Application (2021-2026) Table 43. Global Herpes Treatment Sales Value Share by Application (2027-2032) Table 44. Global Herpes Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Herpes Treatment Sales by Region (2021-2026) & (k units) Table 46. Global Herpes Treatment Sales Market Share by Region (2021-2026) Table 47. Global Herpes Treatment Sales by Region (2027-2032) & (k units) Table 48. Global Herpes Treatment Sales Market Share by Region (2027-2032) Table 49. Global Herpes Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Herpes Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Herpes Treatment Sales Value Share by Region (2021-2026) Table 52. Global Herpes Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Herpes Treatment Sales Value Share by Region (2027-2032) Table 54. Global Herpes Treatment Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global Herpes Treatment Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global Herpes Treatment Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Herpes Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Herpes Treatment Sales by Country (2021-2026) & (k units) Table 59. Global Herpes Treatment Sales Market Share by Country (2021-2026) Table 60. Global Herpes Treatment Sales by Country (2027-2032) & (k units) Table 61. Global Herpes Treatment Sales Market Share by Country (2027-2032) Table 62. Global Herpes Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Herpes Treatment Sales Value Market Share by Country (2021-2026) Table 64. Global Herpes Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Herpes Treatment Sales Value Market Share by Country (2027-2032) Table 66. Abbott Company Information Table 67. Abbott Business Overview Table 68. Abbott Herpes Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Abbott Herpes Treatment Product Portfolio Table 70. Abbott Recent Development Table 71. Teva Pharmaceutical Industries Company Information Table 72. Teva Pharmaceutical Industries Business Overview Table 73. Teva Pharmaceutical Industries Herpes Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Teva Pharmaceutical Industries Herpes Treatment Product Portfolio Table 75. Teva Pharmaceutical Industries Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Herpes Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Novartis Herpes Treatment Product Portfolio Table 80. Novartis Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Herpes Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merck Herpes Treatment Product Portfolio Table 85. Merck Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Herpes Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Mylan Herpes Treatment Product Portfolio Table 90. Mylan Recent Development Table 91. GlaxoSmithKline Company Information Table 92. GlaxoSmithKline Business Overview Table 93. GlaxoSmithKline Herpes Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. GlaxoSmithKline Herpes Treatment Product Portfolio Table 95. GlaxoSmithKline Recent Development Table 96. Vical Company Information Table 97. Vical Business Overview Table 98. Vical Herpes Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Vical Herpes Treatment Product Portfolio Table 100. Vical Recent Development Table 101. Gilead Company Information Table 102. Gilead Business Overview Table 103. Gilead Herpes Treatment Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Gilead Herpes Treatment Product Portfolio Table 105. Gilead Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. Herpes Treatment Distributors List Table 109. Herpes Treatment Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. Herpes Treatment Product Image Figure 2. Global Herpes Treatment Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Herpes Treatment Sales Value (2021-2032) & (US$ Million) Figure 4. Global Herpes Treatment Sales (2021-2032) & (k units) Figure 5. Global Herpes Treatment Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Herpes Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Famciclovir Image Figure 10. Valacyclovir Image Figure 11. Acyclovir Image Figure 12. Global Herpes Treatment Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Herpes Treatment Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Herpes Treatment Sales Volume Share by Type (2021-2032) Figure 15. Global Herpes Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Herpes Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Herpes Treatment Sales Value Share by Type (2021-2032) Figure 18. Retail Pharmacies Image Figure 19. Hospital Pharmacies Image Figure 20. Online Pharmacies Image Figure 21. Drug Stores Image Figure 22. Global Herpes Treatment Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Herpes Treatment Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Herpes Treatment Sales Volume Share by Application (2021-2032) Figure 25. Global Herpes Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Herpes Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Herpes Treatment Sales Value Share by Application (2021-2032) Figure 28. Global Herpes Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Herpes Treatment Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Herpes Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Herpes Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Herpes Treatment Sales Value (2021-2032) & (US$ Million) Figure 33. North America Herpes Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Herpes Treatment Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Herpes Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Herpes Treatment Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Herpes Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Herpes Treatment Sales Value (2021-2032) & (US$ Million) Figure 39. South America Herpes Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Herpes Treatment Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Herpes Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Herpes Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Herpes Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Herpes Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Herpes Treatment Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Herpes Treatment Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Famciclovir
  • Valacyclovir
  • Acyclovir
Applications
  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Drug Stores
Companies covered
  • Abbott
  • Teva Pharmaceutical Industries
  • Novartis
  • Merck
  • Mylan
  • GlaxoSmithKline
  • Vical
  • Gilead

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Herpes Treatment Sales Value (2021-2032)
  4. 1.2.2 Global Herpes Treatment Sales Volume (2021-2032)
  5. 1.2.3 Global Herpes Treatment Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Herpes Treatment Market Dynamics
  1. 2.1 Herpes Treatment Industry Trends
  2. 2.2 Herpes Treatment Industry Drivers
  3. 2.3 Herpes Treatment Industry Opportunities and Challenges
  4. 2.4 Herpes Treatment Industry Restraints
3 Herpes Treatment Market by Company
  1. 3.1 Global Herpes Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Herpes Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Herpes Treatment Sales Volume by Company (2021-2026)
  4. 3.4 Global Herpes Treatment Average Price by Company (2021-2026)
  5. 3.5 Global Herpes Treatment Company Ranking (2024-2026)
  6. 3.6 Global Herpes Treatment Company Manufacturing Base and Headquarters
  7. 3.7 Global Herpes Treatment Company Product Type and Application
  8. 3.8 Global Herpes Treatment Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Herpes Treatment Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Herpes Treatment Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Herpes Treatment Market by Type
  1. 4.1 Herpes Treatment Type Introduction
  2. 4.1.1 Famciclovir
  3. 4.1.2 Valacyclovir
  4. 4.1.3 Acyclovir
  5. 4.2 Global Herpes Treatment Sales Volume by Type
  6. 4.2.1 Global Herpes Treatment Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Herpes Treatment Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Herpes Treatment Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Herpes Treatment Sales Value by Type
  10. 4.3.1 Global Herpes Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Herpes Treatment Sales Value by Type (2021-2032)
  12. 4.3.3 Global Herpes Treatment Sales Value Share by Type (2021-2032)
5 Herpes Treatment Market by Application
  1. 5.1 Herpes Treatment Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Hospital Pharmacies
  4. 5.1.3 Online Pharmacies
  5. 5.1.4 Drug Stores
  6. 5.2 Global Herpes Treatment Sales Volume by Application
  7. 5.2.1 Global Herpes Treatment Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Herpes Treatment Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Herpes Treatment Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Herpes Treatment Sales Value by Application
  11. 5.3.1 Global Herpes Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Herpes Treatment Sales Value by Application (2021-2032)
  13. 5.3.3 Global Herpes Treatment Sales Value Share by Application (2021-2032)
6 Herpes Treatment Regional Sales and Value Analysis
  1. 6.1 Global Herpes Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Herpes Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global Herpes Treatment Sales by Region: 2021-2026
  4. 6.2.2 Global Herpes Treatment Sales by Region (2027-2032)
  5. 6.3 Global Herpes Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Herpes Treatment Sales Value by Region (2021-2032)
  7. 6.4.1 Global Herpes Treatment Sales Value by Region: 2021-2026
  8. 6.4.2 Global Herpes Treatment Sales Value by Region (2027-2032)
  9. 6.5 Global Herpes Treatment Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Herpes Treatment Sales Value (2021-2032)
  12. 6.6.2 North America Herpes Treatment Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Herpes Treatment Sales Value (2021-2032)
  15. 6.7.2 Europe Herpes Treatment Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Herpes Treatment Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Herpes Treatment Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Herpes Treatment Sales Value (2021-2032)
  21. 6.9.2 South America Herpes Treatment Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Herpes Treatment Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Herpes Treatment Sales Value Share by Country, 2025 VS 2032
7 Herpes Treatment Country-level Sales and Value Analysis
  1. 7.1 Global Herpes Treatment Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Herpes Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Herpes Treatment Sales by Country (2021-2032)
  4. 7.3.1 Global Herpes Treatment Sales by Country (2021-2026)
  5. 7.3.2 Global Herpes Treatment Sales by Country (2027-2032)
  6. 7.4 Global Herpes Treatment Sales Value by Country (2021-2032)
  7. 7.4.1 Global Herpes Treatment Sales Value by Country (2021-2026)
  8. 7.4.2 Global Herpes Treatment Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Herpes Treatment Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Herpes Treatment Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Herpes Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Herpes Treatment Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Herpes Treatment Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Herpes Treatment Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Herpes Treatment Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Herpes Treatment Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Herpes Treatment Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Herpes Treatment Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Herpes Treatment Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Herpes Treatment Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Herpes Treatment Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Herpes Treatment Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Herpes Treatment Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Herpes Treatment Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Herpes Treatment Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Herpes Treatment Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Herpes Treatment Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Herpes Treatment Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Herpes Treatment Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Herpes Treatment Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Herpes Treatment Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Herpes Treatment Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Herpes Treatment Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Herpes Treatment Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Herpes Treatment Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Herpes Treatment Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Herpes Treatment Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Herpes Treatment Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Herpes Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Herpes Treatment Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Herpes Treatment Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Teva Pharmaceutical Industries
  8. 8.2.1 Teva Pharmaceutical Industries Company Information
  9. 8.2.2 Teva Pharmaceutical Industries Business Overview
  10. 8.2.3 Teva Pharmaceutical Industries Herpes Treatment Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceutical Industries Herpes Treatment Product Portfolio
  12. 8.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Herpes Treatment Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Herpes Treatment Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Herpes Treatment Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Herpes Treatment Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Herpes Treatment Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Herpes Treatment Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Herpes Treatment Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Herpes Treatment Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 Vical
  38. 8.7.1 Vical Company Information
  39. 8.7.2 Vical Business Overview
  40. 8.7.3 Vical Herpes Treatment Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Vical Herpes Treatment Product Portfolio
  42. 8.7.5 Vical Recent Developments
  43. 8.8 Gilead
  44. 8.8.1 Gilead Company Information
  45. 8.8.2 Gilead Business Overview
  46. 8.8.3 Gilead Herpes Treatment Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Gilead Herpes Treatment Product Portfolio
  48. 8.8.5 Gilead Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Herpes Treatment Value Chain Analysis
  2. 9.1.1 Herpes Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Herpes Treatment Sales Mode & Process
  6. 9.2 Herpes Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Herpes Treatment Distributors
  9. 9.2.3 Herpes Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst